Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Directed Antimicrobial Prophylaxis for TRUSP
NCT01659866Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Aug 2012
- Primary completion
- Aug 2015
- Modality
- Reversible Covalent Inhibitors, Nanoparticles, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 4 trial of trimethoprim + sulfamethoxazole, cefuroxime, ceftriaxone, gentamicin, amikacin in Infection, sponsored by Northwestern University. Started Aug 2012; status: completed.
02
Drugs
trimethoprim + sulfamethoxazolecefuroximeceftriaxonegentamicinamikacin
03
Conditions
Infection
Beyond the preview
Go deeper on NCT01659866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01659866.